Tag: Kigali

  • Lenacapavir Approved by WHO as Long-Acting HIV Prevention Tool

    Lenacapavir Approved by WHO as Long-Acting HIV Prevention Tool

    The World Health Organization (WHO) has issues new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response. The guidelines are being issued at the 13th International AIDS Society Conference (IAS…